Core Laboratories (CLB) Cash from Investing Activities (2022 - 2026)

Core Laboratories' Cash from Investing Activities history runs 5 years deep, the most recent figure standing at -$3.4 million for Q1 2026.

• On a quarterly basis, Cash from Investing Activities fell 539.25% year-over-year to -$3.4 million in Q1 2026; TTM through Mar 2026 was -$6.4 million, a 61.26% decrease from a year earlier, with the FY2025 full-year figure at -$2.2 million, up 65.11% from the prior year.
• Cash from Investing Activities grew to -$3.4 million in Q1 2026 per CLB's latest filing, from -$3.8 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $2.4 million in Q3 2025 and bottomed at -$3.8 million in Q4 2025.
• The 5-year median for Cash from Investing Activities is -$1.7 million (2024), against an average of -$1.3 million.
• Across the five-year window, Cash from Investing Activities surged 587.37% in 2025 and slumped 539.25% in 2026, its largest moves.
• Year by year, Cash from Investing Activities stood at $1.1 million in 2022, then tumbled by 331.19% to -$2.4 million in 2023, then plunged by 45.5% to -$3.6 million in 2024, then declined by 5.42% to -$3.8 million in 2025, then advanced by 9.62% to -$3.4 million in 2026.
• Per Business Quant, the three latest CLB Cash from Investing Activities figures stand at -$3.4 million (Q1 2026), -$3.8 million (Q4 2025), and $2.4 million (Q3 2025).